|
|
| Key Financial Ratios |
|
| Glenmark Pharmaceuticals Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Glenn Saldanha | | Home : Indian Private | Book Value: 651.2259081 | | BSE Code : 532296 | Market Cap: 29742.63 | | NSE Code : GLENMARK | P / E : 28.26 | |
| |
|
|
|
| (Rs in Cr.) |
| Debt-Equity Ratio | 0.20 | 0.24 | 0.26 | 0.27 | 0.27 | | Long Term Debt-Equity Ratio | 0.15 | 0.18 | 0.22 | 0.24 | 0.25 | | Current Ratio | 1.48 | 1.80 | 2.12 | 2.21 | 2.52 | | Fixed Assets | 2.65 | 2.77 | 2.78 | 2.77 | 2.60 | | Inventory | 8.05 | 9.50 | 9.46 | 7.68 | 6.24 | | Debtors | 3.17 | 3.15 | 3.50 | 3.42 | 2.13 | | Interest Cover Ratio | 10.97 | 9.08 | 8.31 | 6.99 | 8.18 | | PBIDTM (%) | 29.84 | 28.29 | 31.19 | 28.75 | 30.72 | | PBITM (%) | 27.60 | 26.33 | 29.20 | 26.68 | 29.04 | | PBDTM (%) | 27.32 | 25.40 | 27.68 | 24.93 | 27.18 | | CPM (%) | 21.44 | 22.15 | 23.79 | 22.24 | 23.02 | | APATM (%) | 19.20 | 20.19 | 21.80 | 20.18 | 21.33 | | ROCE (%) | 10.79 | 10.93 | 12.39 | 11.13 | 12.83 | | RONW (%) | 9.12 | 10.42 | 11.77 | 10.76 | 12.04 |
|
|
|
|
|
|